Lung Cancer Clinical Trial
Beyond the Lung Cancer Diagnosis: Leveraging the Oncology Clinic Setting for Actively Smoking Family Members
Summary
The purpose of this pilot study is to examine, in an innovative setting, the potential for a lung cancer diagnosis in a loved one to represent a teachable moment for smoking cessation in family members or caregivers who are current smokers. The researchers will identify the willingness and preferred modality for smoking cessation among family members/caregivers in this setting. The researchers will estimate abstinence rates at 4, 8, 12, and 24 weeks..
Eligibility Criteria
Patient Inclusion Criteria:
patient with newly diagnosed lung cancer within the last 6 months of initial diagnosis/confirmation of diagnosis at the study sites
Able to provide informed consent
Able to speak and read English
Family Member/Caregiver Participant Criteria:
Family member or caregiver (defined as first degree relative [parent, sibling, child] or person living in the same household)
Family member or caregiver must be a current, active smoker (defined as 10 cigarettes per day for 6 consecutive months).
At least 18 years of age at time of study consent
Able to provide informed consent
Able to speak and read English
Exclusion Criteria:
Currently receiving formal tobacco dependence treatment- Nicotine replacement of any kind, varenicycline or Bupropion.
Medical condition that precludes proposed pharmacotherapy for smoking cessation : Recent (≤ 2 weeks) myocardial infarction , history of underlying arrhythmias , history of serious or worsening angina pectoris, pregnancy and breastfeeding
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Indianapolis Indiana, 46202, United States
How clear is this clinincal trial information?